The relationship between Penicillium and cancer is multifaceted. On one hand, Penicillium-derived penicillin revolutionized the treatment of bacterial infections, indirectly benefiting cancer patients by preventing and treating infections that could complicate chemotherapy and other cancer treatments. On the other hand, some species produce toxic secondary metabolites like mycotoxins, which have been investigated for their potential carcinogenicity.
